Koneksa Health specializes in the development and implementation of digital biomarkers, leveraging advanced digital health technologies to enhance clinical research. Their approach focuses on creating sensitive and accurate measures that can be collected remotely, allowing for continuous data collection from patients in their own environments. This methodology addresses the limitations of traditional clinical assessments, which often rely on infrequent and subjective measures. Koneksa's cloud-based software as a service (SaaS) platform enables real-time data integration from multiple endpoints, facilitating quicker and more informed decision-making throughout the clinical trial process.

The company emphasizes a patient-centric approach, ensuring that the data collected is meaningful both to researchers and patients. Koneksa's expertise spans various therapeutic areas, including oncology and neuroscience, where they develop customized digital biomarker solutions tailored to specific conditions. Their commitment to rigorous validation processes ensures that the digital measures they provide are reliable and scientifically sound. By partnering with leading technology firms, Koneksa enhances its capabilities, offering high-quality digital measurement devices and comprehensive support for remote clinical trials, ultimately aiming to accelerate the delivery of effective therapies to patients.

United States

Koneksa is a leading patient-centric digital biomarker company for the pharmaceutical and biotechnology industries that develops end-to-end solutions for remotely collected clinical data. Koneksa supports agile decision-making in drug development and market strategy. By delivering integrated solutions for efficient trial designs that produce more meaningful data, Koneksa aims to revolutionize effect detection in clinical research.

Koneksa Health

Company Details